Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menthol + simethicone is a combination pharmacological intervention developed by The First Affiliated Hospital of Zhengzhou University for use during colonoscopy procedures. Menthol, a natural terpenoid derived from peppermint oil, functions as a topical antispasmodic by antagonizing L-type calcium channels in intestinal smooth muscle cells, which inhibits calcium influx and leads to muscle relaxation. Simethicone is included as an anti-foaming agent to reduce the surface tension of gas bubbles, thereby improving mucosal visibility and the adenoma detection rate. This combination is administered via endoscopic irrigation as an aqueous suspension to alleviate colonic spasms and enhance the diagnostic quality of the procedure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menthol + simethicone.